Heidelberg Pharma AG Cash Flow Reinvestment Rate
Latest as of May 2022:
0.01x
Heidelberg Pharma AG cash flow reinvestment rate. Heidelberg Pharma AG (HPHA) has a Cash Flow Reinvestment Rate of 0.01x as of May 2022, reinvesting €101.61K (capex €50.81K plus investments €-50.80K) from operating cash flow of €13.59 Million. Explore HPHA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
€101.61K
Capex + Investments
Operating Cash Flow
€13.59 Million
EUR
Capital Expenditures
€50.81K
EUR
Heidelberg Pharma AG Cash Flow Reinvestment Rate by Year (None–None)
Heidelberg Pharma AG cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Heidelberg Pharma AG. For the full cash flow conversion analysis, see Heidelberg Pharma AG (HPHA) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow